Insulin Resistance is Associated with Higher Cerebrospinal Fluid Tau Levels in Asymptomatic APOEɛ4 Carriers - Wikidata - wikimedia - TriplyDB

Insulin Resistance is Associated with Higher Cerebrospinal Fluid Tau Levels in Asymptomatic APOEɛ4 Carriers

Insulin Resistance is Associated with Higher Cerebrospinal Fluid Tau Levels in Asymptomatic APOEɛ4 Carriers

http://www.wikidata.org/entity/Q34468797

about

The roles of lipid and glucose metabolism in modulation of β-amyloid, tau, and neurodegeneration in the pathogenesis of Alzheimer disease Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer's Disease.Modeling the Relationships Among Late-Life Body Mass Index, Cerebrovascular Disease, and Alzheimer's Disease Neuropathology in an Autopsy Sample of 1,421 Subjects from the National Alzheimer's Coordinating Center Data Set Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease.Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence?Associations between Performance on an Abbreviated CogState Battery, Other Measures of Cognitive Function, and Biomarkers in People at Risk for Alzheimer's Disease Biomarker clusters are differentially associated with longitudinal cognitive decline in late midlife Sarcopenia and frailty in older patients with diabetes mellitus.Therapeutic Potential of Antidiabetic Medications in the Treatment of Cognitive Dysfunction and Dementia.Late-Life Vascular Risk Factors and Alzheimer Disease Neuropathology in Individuals with Normal Cognition Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology.Autotaxin is Related to Metabolic Dysfunction and Predicts Alzheimer's Disease Outcomes.Association of Cerebrospinal Fluid (CSF) Insulin with Cognitive Performance and CSF Biomarkers of Alzheimer's Disease.The Wisconsin Registry for Alzheimer's Prevention: A review of findings and current directions.Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums.Relationship of Type 2 Diabetes to Human Brain Pathology.Association of longitudinal white matter degeneration and cerebrospinal fluid biomarkers of neurodegeneration, inflammation and Alzheimer's disease in late-middle-aged adults.Insulin Resistance as a Therapeutic Target in the Treatment of Alzheimer's Disease: A State-of-the-Art Review.

P2860

Q26777969-67698D72-D6E9-4FF8-9075-1A67A3D4C465 Q33628048-96E984A5-4678-42E1-93D7-B8224386E1E2 Q33926397-CA66AC7E-DA02-4597-B21B-61E09D97A766 Q36062457-9C32A25A-BFC1-4D33-B169-27084CBB526B Q37179048-4F16F14F-AA8D-4625-8B09-02489FD85CDD Q37358410-999B384C-46CF-49B9-A20C-22A673E81554 Q38391075-88438AF6-9835-4B48-899D-5E360B028DCE Q38707986-8F4661E0-DB76-46CE-9007-39298C25B432 Q38823805-399EAA08-272E-44E6-BCF4-1551E7FC7209 Q39497338-7B1F8D07-E55B-490D-80EE-3175B4BC93FE Q40059968-DD1EB9CF-0777-49F1-9856-BDBB04564AB3 Q42642222-9A0D4A15-57F1-4282-BCC2-01DD7D69C792 Q47149070-9120F0CE-2BF4-497F-8BE5-8C7FAC6E598D Q47646484-F9FCE461-0014-48E1-AA77-8B08DBEE1ED0 Q47835103-1C15754C-0DFC-4E36-A110-91E6F58FEBA2 Q50103147-7F985F8B-1A99-43CB-954E-25055C44CD6F Q50591921-BF859793-0EBB-45F1-B09A-DE6F9C442AA1 Q53685113-8C3A3400-9E37-4492-879E-7734E26F0784

P2860

Insulin Resistance is Associated with Higher Cerebrospinal Fluid Tau Levels in Asymptomatic APOEɛ4 Carriers

http://www.wikidata.org/entity/Q34468797

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Insulin Resistance is Associat ...... n Asymptomatic APOEɛ4 Carriers

@ast

Insulin Resistance is Associat ...... n Asymptomatic APOEɛ4 Carriers

@en

Insulin Resistance is Associat ...... n Asymptomatic APOEɛ4 Carriers

@nl

type

label

Insulin Resistance is Associat ...... n Asymptomatic APOEɛ4 Carriers

@ast

Insulin Resistance is Associat ...... n Asymptomatic APOEɛ4 Carriers

@en

Insulin Resistance is Associat ...... n Asymptomatic APOEɛ4 Carriers

@nl

prefLabel

Insulin Resistance is Associat ...... n Asymptomatic APOEɛ4 Carriers

@ast

Insulin Resistance is Associat ...... n Asymptomatic APOEɛ4 Carriers

@en

Insulin Resistance is Associat ...... n Asymptomatic APOEɛ4 Carriers

@nl

P1433

Q34468797-7314C91F-BAF0-4256-AAC4-36343F95C49E

P1476

Q34468797-5017AB68-0231-4B0C-8D2E-845B7F7F7224

P2093

Q34468797-066C7ED1-C732-43F7-A666-A01CDCECB01A

Q34468797-0CEC9657-0E47-4D96-86DE-B6CB6AD14D2A

Q34468797-1BBD1B07-9BE5-4D3F-9A50-1EA3BA1616B7

Q34468797-2F3E24C7-0741-42F8-959C-F376A396660A

Q34468797-5E07BF92-321D-4664-832F-30233D15131F

Q34468797-6BCCEF9F-A9A2-441F-A1F5-5CE29C65E8E5

Q34468797-939161C0-1240-4E3E-8676-77A5AF7D2B86

Q34468797-959FB1EC-8292-40AD-AF9C-07F3ADDA81D7

Q34468797-9D5F0A2F-370C-4937-908C-2E41F59533AE

Q34468797-9D8ACF81-6657-428C-9BB5-DA2222264006

P2860

Q34468797-01603C2A-4485-4B39-8B65-7C899C089864

Q34468797-047FB403-EC4F-4DA0-9F4F-B589DB94EF9D

Q34468797-070D537B-0624-483C-8367-A80C2517D517

Q34468797-0FF809A4-8864-4A4E-A071-6F831ABAB953

Q34468797-1436DFE6-5A3E-465F-8C80-23A72ED7620C

Q34468797-19BF9F7A-16F8-431F-B056-E2AC29882160

Q34468797-1DFFA0BD-E107-4800-8E7A-43D36AE3E9BE

Q34468797-20D46F55-07E8-465E-8B4D-DE1E6E3538F0

Q34468797-2333852B-45EF-4090-8927-29EACA1BF68E

Q34468797-2BD420EF-C043-4C2F-8185-9F84A9E96FB9

P304

Q34468797-2A6A4892-DB57-4088-BC2C-B06C157F8699

P31

Q34468797-9DAA3581-F65C-4175-99FC-6282D35E26E3

P356

Q34468797-14D0B206-6564-4510-B2F3-88E658ACE279

P433

Q34468797-E311E1CA-786B-4353-AACA-21E107EEBAC2

P478

Q34468797-809C9829-8F1A-49B9-B1D1-6783468D6373

P50

Q34468797-13DB2701-FC5B-4447-9930-FC4579549474

Q34468797-FAE0AC94-436F-4370-B116-8A4C9505E506

P577

Q34468797-C1B9D8F6-6DCC-437B-B7E0-7ED1E9AC2817

P698

Q34468797-583901B9-582B-4F36-B8E5-BBFFFA1DFA9B

P921

Q34468797-A2D1CEA8-FF83-473F-81C0-39028F80463A

Q34468797-F505752C-0462-4275-8153-EF0DFF0F9303

P932

Q34468797-185CA429-91BC-4F7F-ABB8-241BDAE6C0B4

P356

P1433

Journal of Alzheimer's Disease

P1476

Insulin Resistance is Associat ...... n Asymptomatic APOEɛ4 Carriers

@en

P2093

Annie M Racine

http://www.w3.org/2001/XMLSchema#string

Barbara B Bendlin

http://www.w3.org/2001/XMLSchema#string

Carey E Gleason

http://www.w3.org/2001/XMLSchema#string

Cynthia M Carlsson

http://www.w3.org/2001/XMLSchema#string

Erika J Starks

http://www.w3.org/2001/XMLSchema#string

J Patrick O'Grady

http://www.w3.org/2001/XMLSchema#string

LeAnn M DeRungs

http://www.w3.org/2001/XMLSchema#string

Luigi Puglielli

http://www.w3.org/2001/XMLSchema#string

Mark A Sager

http://www.w3.org/2001/XMLSchema#string

N Maritza Dowling

http://www.w3.org/2001/XMLSchema#string

P2860

Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Alzheimer's disease

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?

A "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease.

Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study.

Optimal reference interval for homeostasis model assessment of insulin resistance in a Japanese population.

Increased Alzheimer's disease neuropathology is associated with type 2 diabetes and ApoE ε.4 carrier status.

The definition of insulin resistance using HOMA-IR for Americans of Mexican descent using machine learning.

P304

525-533

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/JAD-150072

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P50

Henrik Zetterberg

P577

2015-03-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25812851

http://www.w3.org/2001/XMLSchema#string

P921

cerebrospinal fluid

P932

4583335

http://www.w3.org/2001/XMLSchema#string